Quest Laboratories Ltd
NSE: QUESTLAB
₹99.65
₹-1.40
(-1.39%)
As on 15-Jun-2026IST
Market cap
₹163 Cr
Revenue (TTM)
₹112 Cr
P/E Ratio
10.9
P/B Ratio
1.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹15 Cr
-
ROE
24.6 %
-
ROCE
26.9 %
-
Industry P/E
41.12
-
EV/EBITDA
8.2
-
Debt to Equity
0
-
Book Value
₹59.1
-
EPS
₹9.2
-
Face value
10
-
Shares outstanding
16,387,200
5 Years Aggregate
CFO
₹-11.93 Cr
EBITDA
₹47.27 Cr
Net Profit
₹33.47 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Quest Laboratories
| -9.5 | -9.9 | -11.0 | 8.3 | -- | -- | -- |
|
BSE Healthcare
| 8.6 | 0.1 | 10.2 | 7.2 | 24.4 | 13.1 | 12.1 |
|
Company
|
2025
|
|---|---|
|
Quest Laboratories
| -6.9 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Quest Laboratories
|
99.7 | 163.3 | 111.8 | 15.0 | 15.6 | 16.1 | 10.9 | 1.7 |
| 3,096.7 | 25,332.2 | 1,339.4 | 356.4 | 33.2 | 23.2 | 71.1 | 15.3 | |
| 427.0 | 16,314.6 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91 | 4.2 | |
| 748.5 | 18,561.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.2 | 3.7 | |
| 991.4 | 15,800.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.7 | 2.2 | |
| 1,623.4 | 18,619.6 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 167.2 | 22,266.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.7 | |
| 1,344.4 | 22,215.9 | 1,284.3 | 134.4 | -- | 30.7 | 90 | 17.2 | |
| 453.5 | 18,274.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 57.7 | 3.8 | |
| 1,907.6 | 30,998.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 145.5 | 6.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Quest Laboratories
--
-
Incorporated
1998
-
Chairman
--
-
Managing Director
Anil Kumar Sabarwal
-
Headquarters
Dhar, Madhya Pradesh
-
Website
Looking for more details about Quest Laboratories Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Quest Laboratories
What is the current share price of Quest Laboratories Ltd Today?
The share price of Quest Laboratories Ltd is ₹99.65 (NSE) as of 15-Jun-2026 IST. Quest Laboratories Ltd has given a return of 8.32% in the last 1 years.
What is the current PB & PE ratio of Quest Laboratories Ltd?
The P/E ratio of Quest Laboratories Ltd is 10.87 times as on 15-Jun-2026, a 74 discount to its peers’ median range of 41.12 times.
The P/B ratio of Quest Laboratories Ltd is 1.69 times as on 15-Jun-2026, a 56 discount to its peers’ median range of 3.87 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
12.38
|
2.05
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Quest Laboratories Ltd?
The 52-week high and low of Quest Laboratories Ltd are Rs 152.60 and Rs 82.00 as of 16-Jun-2026.
What is the market cap of Quest Laboratories Ltd?
Quest Laboratories Ltd has a market capitalisation of ₹ 163 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Quest Laboratories Ltd?
Before investing in Quest Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.